Crossmark

A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis

Crossref DOI link: https://doi.org/10.1007/s10620-018-5449-x

Published Online: 2019-01-19

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oliva, Salvatore https://orcid.org/0000-0003-2348-2308
Rossetti, Danilo

Papoff, Paola

Tiberti, Antonio

Mallardo, Saverio

Volpe, Danila

Ruggiero, Cosimo

Russo, Giusy

Vezzoli, Debora

Isoldi, Sara

Cucchiara, Salvatore
License Information

Text and Data Mining valid from 2019-01-19
More Information

Article History

Received: 10 July 2018

Accepted: 29 December 2018

First Online: 19 January 2019

Compliance with ethical standards

:

: ITC Farma provided the entire budesonide supply used in the study. Apart from the provision of the drug, no financial support from the company was received for this study. All authors have no conflict of interest to declare.